Detalles de la búsqueda
1.
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis.
Hepatology
; 66(1): 13-26, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28195337
2.
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.
Clin Gastroenterol Hepatol
; 15(1): 132-136, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27392759
3.
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer.
Thyroid
; 32(7): 799-806, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35521657
4.
Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study.
Metabol Open
; 10: 100090, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33889834
5.
Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy.
JCO Precis Oncol
; 32019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31485558
6.
Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients.
Hepatol Int
; 10(5): 789-98, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27443347
7.
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.
Lancet Gastroenterol Hepatol
; 1(2): 97-104, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27917405
8.
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data.
PLoS One
; 11(6): e0155934, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27276081
Resultados
1 -
8
de 8
1
Próxima >
>>